Sareum Holdings plc (AIM:SAR)
London · Delayed Price · Currency is GBP · Price in GBX 20.00
-0.25 (-1.23%)
May 6, 2026, 5:08 PM GMT
Sareum Holdings Market Cap
Sareum Holdings has a market cap or net worth of 27.96 million as of May 6, 2026. Its market cap has increased by 21.42% in one year.
Market Cap
27.96M
Enterprise Value
25.47M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.00
Market Cap Chart
Since December 6, 2004, Sareum Holdings's market cap has increased from 8.69M to 27.96M, an increase of 221.59%. That is a compound annual growth rate of 5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 27.96M | 35.00% |
| Dec 31, 2025 | 20.71M | -32.34% |
| Dec 31, 2024 | 30.61M | -26.79% |
| Dec 29, 2023 | 41.81M | -25.56% |
| Dec 30, 2022 | 56.16M | -66.33% |
| Dec 31, 2021 | 166.77M | 110.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 61.05M |
| hVIVO | 50.15M |
| Hemogenyx Pharmaceuticals | 43.47M |
| Poolbeg Pharma | 30.32M |
| ImmuPharma | 25.83M |
| SkinBioTherapeutics | 25.27M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 21.59M |